Literature DB >> 11581413

Cytopathic effects of non-syncytium-inducing and syncytium-inducing human immunodeficiency virus type 1 variants on different CD4(+)-T-cell subsets are determined only by coreceptor expression.

D Kwa1, J Vingerhoed, B Boeser-Nunnink, S Broersen, H Schuitemaker.   

Abstract

In peripheral blood mononuclear cells, syncytium-inducing (SI) human immunodeficiency virus type 1 (HIV-1) infected and depleted all CD4(+) T cells, including naive T cells. Non-SI HIV-1 infected and depleted only the CCR5-expressing T-cell subset. This may explain the accelerated CD4 cell loss after SI conversion in vivo.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11581413      PMCID： PMC114619          DOI： 10.1128/JVI.75.21.10455-10459.2001

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  35 in total

1.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.

Authors:  T Dragic; V Litwin; G P Allaway; S R Martin; Y Huang; K A Nagashima; C Cayanan; P J Maddon; R A Koup; J P Moore; W A Paxton
Journal:  Nature       Date:  1996-06-20       Impact factor: 49.962

2.  The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.

Authors:  H Choe; M Farzan; Y Sun; N Sullivan; B Rollins; P D Ponath; L Wu; C R Mackay; G LaRosa; W Newman; N Gerard; C Gerard; J Sodroski
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

3.  CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

Authors:  G Alkhatib; C Combadiere; C C Broder; Y Feng; P E Kennedy; P M Murphy; E A Berger
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

4.  The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.

Authors:  C C Bleul; L Wu; J A Hoxie; T A Springer; C R Mackay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

5.  The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.

Authors:  G R Picchio; R J Gulizia; K Wehrly; B Chesebro; D E Mosier
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen.

Authors:  N Sachsenberg; A S Perelson; S Yerly; G A Schockmel; D Leduc; B Hirschel; L Perrin
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

7.  A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.

Authors:  B J Doranz; J Rucker; Y Yi; R J Smyth; M Samson; S C Peiper; M Parmentier; R G Collman; R W Doms
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

8.  Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1.

Authors:  B Schramm; M L Penn; E H Palacios; R M Grant; F Kirchhoff; M A Goldsmith
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Evidence for the HIV-1 phenotype switch as a causal factor in acquired immunodeficiency.

Authors:  S Glushakova; J C Grivel; W Fitzgerald; A Sylwester; J Zimmerberg; L B Margolis
Journal:  Nat Med       Date:  1998-03       Impact factor: 53.440

10.  T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).

Authors:  M D Hazenberg; J W Stuart; S A Otto; J C Borleffs; C A Boucher; R J de Boer; F Miedema; D Hamann
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113
View more
  14 in total

1.  R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.

Authors:  Becky Schweighardt; Ann-Marie Roy; Duncan A Meiklejohn; Edward J Grace; Walter J Moretto; Jonas J Heymann; Douglas F Nixon
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

2.  R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression.

Authors:  Shailesh K Choudhary; Neelima R Choudhary; Katherine C Kimbrell; Jonathan Colasanti; Argyrios Ziogas; David Kwa; Hanneke Schuitemaker; David Camerini
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4+ T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and Maintained.

Authors:  Michael Roche; Carolin Tumpach; Jori Symons; Matthew Gartner; Jenny L Anderson; Gabriela Khoury; Kieran Cashin; Paul U Cameron; Melissa J Churchill; Steven G Deeks; Paul R Gorry; Sharon R Lewin
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

4.  Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication.

Authors:  Nathalie Schmitt; Laurent Chêne; David Boutolleau; Marie-Thérèse Nugeyre; Eric Guillemard; Pierre Versmisse; Catherine Jacquemot; Françoise Barré-Sinoussi; Nicole Israël
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells.

Authors:  Andreas Jekle; Oliver T Keppler; Erik De Clercq; Dominique Schols; Mark Weinstein; Mark A Goldsmith
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure.

Authors:  Geoffrey H Holm; Chengsheng Zhang; Paul R Gorry; Keith Peden; Dominique Schols; Erik De Clercq; Dana Gabuzda
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Reduced frequency of memory T cells and increased Th17 responses in patients with active tuberculosis.

Authors:  Nancy D Marín; Sara C París; Mauricio Rojas; Luis F García
Journal:  Clin Vaccine Immunol       Date:  2012-08-22

8.  In vivo evolution of X4 human immunodeficiency virus type 1 variants in the natural course of infection coincides with decreasing sensitivity to CXCR4 antagonists.

Authors:  Evelien H B Stalmeijer; Ronald P Van Rij; Brigitte Boeser-Nunnink; Janny A Visser; Marloes A Naarding; Dominique Schols; Hanneke Schuitemaker
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Comparison of human immunodeficiency virus type 1 tropism profiles in clinical samples by the Trofile and MT-2 assays.

Authors:  Eoin Coakley; Jacqueline D Reeves; Wei Huang; Marga Mangas-Ruiz; Irma Maurer; Agnes M Harskamp; Soumi Gupta; Yolanda Lie; Christos J Petropoulos; Hanneke Schuitemaker; Angélique B van 't Wout
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

10.  Characterization of peripheral blood human immunodeficiency virus isolates from Hispanic women with cognitive impairment.

Authors:  Dianedis M Toro Nieves; Marinés Plaud; Valerie Wojna; Richard Skolasky; Loyda M Meléndez
Journal:  J Neurovirol       Date:  2007-08       Impact factor: 2.643
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.